Stock Events

Stock Events

KalVista Pharmaceuticals (KALV) Q1 2024 Earnings

11MarConfirmed

Q2 2023

Q2 2023

Q3 2023

Q1 2024

-0.94

-0.87

-0.81

-0.74

Details

Expected EPS

-0.747167

Actual EPS

-0.84

Surprise EPS

-0.09

Surprise Percent

+12.42%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -0.84 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.